Real-life outcomes of unselected acute promyelocytic leukemia patients: a single-center 14-year experience

Background. After the inclusion of all-trans retinoic acid (ATRA) into the treatment of Acute Promyelocytic leukemia (APL), a notable improvement concerning the survival rates of patients with APL has been observed. However, the population-based studies demonstrated that there was no marked improvem...

Full description

Bibliographic Details
Main Authors: Akcay Omer Faruk, Yeter Haci Hasan, Buyukasik Yahya
Format: Article
Language:English
Published: Sciendo 2020-09-01
Series:Romanian Journal of Internal Medicine
Subjects:
Online Access:https://doi.org/10.2478/rjim-2020-0011